LeonaBio, Inc.
LONA
$11.26
$0.262.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -36.08% | -28.85% | -16.57% | -20.47% | -21.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -64.68% | -64.89% | -52.32% | -37.11% | -23.86% |
| Operating Income | 64.68% | 64.89% | 52.32% | 37.11% | 23.86% |
| Income Before Tax | -8.94% | 65.46% | 47.24% | 31.37% | 17.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.94% | 65.46% | 47.24% | 31.37% | 17.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.94% | 65.46% | 47.24% | 31.37% | 17.62% |
| EBIT | 64.68% | 64.89% | 52.32% | 37.11% | 23.86% |
| EBITDA | 65.34% | 65.46% | 52.74% | 37.39% | 24.04% |
| EPS Basic | 15.48% | 66.04% | 47.93% | 32.17% | 18.55% |
| Normalized Basic EPS | 64.49% | 65.35% | 52.38% | 36.79% | 23.22% |
| EPS Diluted | 15.48% | 66.04% | 47.93% | 32.17% | 18.55% |
| Normalized Diluted EPS | 64.49% | 65.35% | 52.38% | 36.79% | 23.22% |
| Average Basic Shares Outstanding | 11.11% | 1.93% | 1.63% | 1.42% | 1.21% |
| Average Diluted Shares Outstanding | 11.11% | 1.93% | 1.63% | 1.42% | 1.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |